36.86 +0.08 (0.22%)
VRTX
| Trade VRTX now with |
|
Stock Details
Last Trade:36.86 Change:+0.08 (0.22%) Prev Close:36.78 Open: 37.13 Days Range:35.98 – 37.23 52 Week Range: 26.50 - 58.87 Volume:2071423 P/E: 263.29EPS:0.14
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 7:19am
Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target
Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target
Wells Fargo downgraded WuXi PharmaTech (NYSE: WX) from Outperform to Market Perform, price target range $14-$15.Wells analyst says, "Unsubstantiated speculation of a takeout has driven the stock price up 30% since January 1 compared to about 7% for... Read More
Recent Alert on 02/06/12 at 7:19am
Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target
Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target
Recent Alert on 02/03/12 at 10:51am
Notable Analyst Rating Changes 02/03: (DNDN) (BBT) (NOV) Upgraded; (RIMM) (VRTX) (AET) Downgraded
Notable Analyst Rating Changes 02/03: (DNDN) (BBT) (NOV) Upgraded; (RIMM) (VRTX) (AET) Downgraded
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/06/12 at 4:16pm
Form 4 VERTEX PHARMACEUTICALS For: Feb 02 Filed by: Stamoulis Christiana
Form 4 VERTEX PHARMACEUTICALS For: Feb 02 Filed by: Stamoulis Christiana
View AllRecent Blog Posts
Blog Posts on 02/08/12 at 7:08pm
Analyzing Tuesday's Noteworthy Insider Buys And Sells In Healthcare And Technology
Analyzing Tuesday's Noteworthy Insider Buys And Sells In Healthcare And Technology
Blog Posts on 02/07/12 at 2:36am
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management